BioSpace News Archive

NEUVOGEN, an immunoncology company, is pleased to announce the appointment of Dr. Mark W. Frohlich, MD to its Board of Directors and Scientific Advisory Board (“SAB”) effective August 23, 2021.

LUNGevity Foundation, the nation’s leading lung cancer-focused nonprofit organization, is pleased to offer, in partnership with patient advocacy group RETpositive, a new lung cancer research award program to support research that will transform the future for patients diagnosed with RET-positive lung cancer by changing it into a chronic or curable condition.

Sorrento Therapeutics, Inc. (Nasdaq: SRNE, “Sorrento”) today released a patient case report on the lymphatic delivery of Enbrel using the Sofusa Lymphatic Delivery System (SOFUSA),

PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that the Brazilian Health Regulatory Agency, ANVISA (Agência Nacional de Vigilância Sanitária), has approved Waylivra™ (volanesorsen) as the first treatment for familial chylomicronemia syndrome (FCS) in Brazil.

Disc Medicine today announced the promotions of Will Savage, MD, PhD to Chief Medical Officer and Jonathan Yu to Chief Business Officer.

Hyperfine Inc. today announced the appointment of Alok Gupta as the company’s chief financial officer.

The Hanger Foundation today announced the 2021 recipients of the inaugural Hanger Foundation Diversity Scholarships.

MedX Health Corp. (“MedX” or the “Company”) ( MDX – TSXV), announces that at the Annual and Special General Meeting of shareholders held on August 16, 2021, Rob von der Porten retired as a director, thus creating a vacancy on the Board.

Antengene Corporation Limited (“Antengene”, SEHK: 6996.HK), today announced that China’s National Medical Products Administration has approved a Phase II study of selinexor (XPOVIO®) for the treatment of patients with myelofibrosis (MF).

Cara Therapeutics (Nasdaq: CARA) and Vifor Pharma today announced that the U.S. Food and Drug Administration (FDA) has approved KORSUVA™ (difelikefalin) for injection for the treatment of moderate-to-severe pruritus associated with chronic kidney disease in adults undergoing hemodialysis